Karolinska Development company Umecrine Cognition to present at the EASL International Liver Congress 2017

World News: . []

STOCKHOLM - April 21 2017 Karolinska Developments Nasdaq Stockholm: KDEV portfolio company Umecrine Cognition AB whose novel orally-active GABAA receptor modulating steroid, GR3027 is in clinical development for hepatic encephalopath y (HE),...

More news and information about Karolinska Development AB (publ)

Published By:

Thomson Reuters: 07:01 GMT Friday 21st April 2017

Published: .

Search for other references to "karolinska" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2017. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us
 

Advertising on SPi News: Information For Advertisers